Cancer Center Research

UNMC researchers publish findings on herpes simplex virus

The team determined the structure of the helicase-primase complex, offering a target for future antiviral therapies.

Nov 14, 2025

Tahir Tahirov, PhD

Research leadership: Vijaya Bhatt, MBBS

Dr. Bhatt is a professor in the UNMC Department of Internal Medicine, Division of Oncology and Hematology.

Oct 31, 2025

Vijaya Bhatt, MBBS

UNMC researchers to study obesity and its cancer risks

Mariah Jackson, PhD, and Dana Verhoeven, PhD, received grant funding from the National Institutes of Health.

Oct 27, 2025

Mariah Jackson, PhD, and Dana Verhoeven, PhD

Dr. Sweasy to confront rural cancer as new AACI president

Joann Sweasy, PhD, became president of the Association of American Cancer Institutes on Oct. 21.

Oct 22, 2025

Joann Sweasy, PhD

New investigator: Maher Abdalla, PhD

Dr. Abdalla is an associate professor in the UNMC Department of Pathology, Microbiology and Immunology.

Oct 10, 2025

Maher Abdalla, PhD

Upper Midwest Emerging Scholars

Regional exchange program helps early-career cancer researchers build collaborations and accelerate their scientific careers across Upper Midwest institutions.

Sep 30, 2025

From left: Jingjing Sun, PhD, Sandipan Brahma, PhD, Grinu Mathew, PhD

Midwest cancer symposium is Oct. 7 at UNMC

The event will explore environmental determinants of pediatric cancer and congenital anomalies.

Sep 15, 2025

UNMC panelists include Julie Petersen, PhD, Jesse Bell, PhD, and Tara Nordgren, PhD.

UNMC achievements: Sept. 12, 2025

Two NIH grants of note, a distinguished mentor of graduate students award and an award for a glycobiology leader.

Sep 12, 2025

Brittney Dickey, PhD

Leading the charge against breast cancer

The Fred & Pamela Buffett Cancer Center has a goal to create an endowed chair with a special legacy: the Kenneth Cowan, MD, PhD, Distinguished Chair in Breast Cancer Clinical Research.

Sep 2, 2025

Ken Cowan, MD, PhD

Nebraska Medicine patient is first to receive new MS therapy

A first-of-its-kind clinical trial is examining the effectiveness of allogeneic CAR T-Cell therapy.

Aug 6, 2025

Nebraska Medicine patient Jan Janisch-Hanzlik is first in the world to receive a new allogeneic CAR T-Cell therapy for multiple sclerosis.